A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata. [PDF]
Cha-Silva AS +6 more
europepmc +1 more source
Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis. [PDF]
Deng Y, Li C, Cheng L, Wang S, Tao X.
europepmc +1 more source
Kerion in Disguise: Avoiding Surgical Misdiagnosis in Adolescent Scalp Lesions. [PDF]
Paudyal A, Regmi P, Agrawal S.
europepmc +1 more source
The different face of skin‐rash induced by brentuximab vedotin
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri +11 more
wiley +1 more source
Alopecia areata during dupilumab therapy: 2 cases and review of the literature. [PDF]
Almulhim AN +5 more
europepmc +1 more source
Consensus‐based Guideline on tinea capitis
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser +19 more
wiley +1 more source
Public Interest in Janus Kinase (JAK) Inhibitors for Alopecia Areata: A Google Trend Analysis. [PDF]
Howard J +3 more
europepmc +1 more source
PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa
Journal of Cutaneous Pathology, EarlyView.
Annie Jin +2 more
wiley +1 more source
Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges - A Narrative Review. [PDF]
Khoda F +5 more
europepmc +1 more source

